SLV News 20.08 07/24/2014 05:40:54 Silver Trust Ishares (SLV

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Silver Trust Ishares (SLV) 20.08 $SLV

Pan American Silver Is Just 1 Way to Invest in Silver
Lior Cohen, The Motley Fool - Motley Fool - Thu Jul 17, 1:17PM CDT
The silver market is slowly making a comeback after silver prices took a dive last year. The price of silver is now up by 11% this year. For investors thinking of entering the silver market, what are the main ways to invest in this precious metal?...

iShares Silver Trust (SLV) : Take profit @ $20.12
Trading Central - Tue Jul 15, 8:32AM CDT
The iShares Silver Trust is losing upward momentum as it is reversing down from its upper Bollinger band. We prefer to take profit right now at last price ($20.12) on long position opened in May 5th. Trading strategy: Close our long position at...

Watch for iShares Silver Trust to Potentially Rebound After Falling 2.28% Yesterday
Comtex SmarTrend(R) - Mon Jul 14, 4:23PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $20.01 to a high of $20.14. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $20.15 on volume of 8.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Silver Trust Set to Possibly Rebound After Yesterday's Selloff of 2.28%
Comtex SmarTrend(R) - Mon Jul 14, 4:22PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $20.01 to a high of $20.14. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $20.15 on volume of 8.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iShares Silver Trust to Potentially Pullback after Yesterday's 1.23% Rise
Comtex SmarTrend(R) - Thu Jul 10, 4:24PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $20.51 to a high of $20.64. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $20.39 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iShares Silver Trust to Potentially Pullback After Gaining 1.23% Yesterday
Comtex SmarTrend(R) - Thu Jul 10, 4:24PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $20.51 to a high of $20.64. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $20.39 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Are Gold and the Dow Both Falling Today?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Jul 07, 12:32PM CDT
Recently, the gold market has often moved in the opposite direction as the stock market, with the Dow Jones Industrials  setting more than four dozen highs in 2013 even as the yellow metal plunged to its lowest levels in years. The Dow was down 55...

'Fast Money' Recap: Waiting on the Jobs Report
at The Street - Thu Jul 03, 4:00AM CDT
The trading panel discussed the Dow's record high and how jobs data on a holiday-shortened week can affect investors.

Do Geopolitics Still Have a Firm Hold on Commodities, Oil, Gold?
at The Street - Fri Jun 27, 12:33PM CDT
Middle Eastern tensions might seem bullish for oil. But there are other factors to consider for commodities investors.

'Fast Money' Recap: Can GM Shares Drive Through $38?
at The Street - Thu Jun 26, 4:00AM CDT
The trading panel discussed whether General Motors and Google are worth buying.

Look for Shares of iShares Silver Trust to Potentially Pullback after Yesterday's 4.57% Rise
Comtex SmarTrend(R) - Thu Jun 19, 3:43PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $19.36 to a high of $20.10. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $19.07 on volume of 24.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Reasons to Buy Silver Wheaton Corp Over Silver ETFs
Lior Cohen, The Motley Fool - Motley Fool - Wed Jun 18, 2:56PM CDT
In the past couple of weeks, the silver market has slowly recovered, raising investor interest in silver-related assets such as the  iShares Silver Trust .  Silver Wheaton , however, may offer several advantages over a direct investment in a silver...

Iraq’s ISIS Crisis: What Investors Need to Know
Leo Sun, The Motley Fool - Motley Fool - Wed Jun 18, 12:20PM CDT
ISIS, or The Islamic State in Iraq and the Levant, also known as ISIL, a militant group once deemed too violent and radical by al-Qaeda, is currently sweeping across both Iraq and Syria in an aggressive push to unify both nations into a single state....

How the Silver Market Gets Hurt by the World Cup
at The Street - Mon Jun 16, 10:30AM CDT
UBS explains why the silver market will see even slower trading during the next month compared against prior summers.

SmarTrend Watching for Potential Pullback in Shares of iShares Silver Trust After 1.63% Gain
Comtex SmarTrend(R) - Thu Jun 12, 4:31PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.52 to a high of $18.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $18.50 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Silver Trust Set to Possibly Pullback After Yesterday's Rally of 1.63%
Comtex SmarTrend(R) - Thu Jun 12, 4:31PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.52 to a high of $18.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $18.50 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Reasons Why Gold Continues to Flatline
James Catlin, The Motley Fool - Motley Fool - Wed Jun 11, 8:56AM CDT
If you're puzzled why large injections into the money supply have failed to send gold prices higher, you're not alone. The answer is not so simple, since many factors can have an impact on the price of gold. For now we will forget about politics and...

Non-Farm Payroll Data Just May Boost the Gold, Silver Market
at The Street - Thu Jun 05, 9:49AM CDT
Tomorrow the non-farm payroll report will be released; how the report will impact the gold market?

Precious Metals: A Golden Fall
at The Street - Mon Jun 02, 10:35AM CDT
Good new and bad news this week. Gold is in serious trouble -- but that means prices are low.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading